Agarwal Arjun sold 533 shares of Oruka Therapeutics, Inc. at $95.75 for −$51.0k on Sep 21, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Senior Vice President, Finance
Senior Vice President, Finance
Filed Sep 21, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$51,034.75Shares × reported price
Shares traded
533Common Stock
Price per share
$95.75Reported price. Read footnotes for ranges.
% of reported position traded
3.61%This security and ownership context
Holdings after
14,219Direct
Trade date
Sep 21, 2026Sell
Filed
Sep 21, 2026, 5:38 PM ET0-day reporting delay
Accession
0000907654-26-000102Code S · Transaction 226972
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 14,752 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ORKA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ORKA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +16%1w ago +2.7%1d ago +1.7%
Returns since7d −9.8%30d −14%90d180d1y

Footnotes in full

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.